NO20044530L - Fremgangsmate for behandling av kognitive forstyrrelser - Google Patents
Fremgangsmate for behandling av kognitive forstyrrelserInfo
- Publication number
- NO20044530L NO20044530L NO20044530A NO20044530A NO20044530L NO 20044530 L NO20044530 L NO 20044530L NO 20044530 A NO20044530 A NO 20044530A NO 20044530 A NO20044530 A NO 20044530A NO 20044530 L NO20044530 L NO 20044530L
- Authority
- NO
- Norway
- Prior art keywords
- cognitive disorders
- procedure
- treatment
- phenylcanamoyleseroline
- alzheimer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36706802P | 2002-03-22 | 2002-03-22 | |
| US10/386,915 US20040024043A1 (en) | 2002-03-22 | 2003-03-12 | Method for treating cognitive disorders |
| PCT/US2003/008407 WO2003082270A1 (en) | 2002-03-22 | 2003-03-18 | Method for treating cognitive disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20044530L true NO20044530L (no) | 2004-10-21 |
Family
ID=28678179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20044530A NO20044530L (no) | 2002-03-22 | 2004-10-21 | Fremgangsmate for behandling av kognitive forstyrrelser |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20040024043A1 (ko) |
| EP (1) | EP1490057A4 (ko) |
| JP (1) | JP2005526806A (ko) |
| KR (1) | KR100609381B1 (ko) |
| CN (1) | CN1642541A (ko) |
| AU (1) | AU2003230683B2 (ko) |
| BR (1) | BR0306855A (ko) |
| CA (1) | CA2476923A1 (ko) |
| HR (1) | HRP20040992A2 (ko) |
| IL (1) | IL163993A0 (ko) |
| MX (1) | MXPA04009136A (ko) |
| NO (1) | NO20044530L (ko) |
| NZ (1) | NZ534726A (ko) |
| PL (1) | PL372315A1 (ko) |
| RU (1) | RU2280449C2 (ko) |
| WO (1) | WO2003082270A1 (ko) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2309594T3 (es) * | 2003-11-21 | 2008-12-16 | Memory Pharmaceuticals Corporation | Composiciones que contienen bloqueadores de los canales de calcio de tipo l e inhibidores de la colinesterasa. |
| WO2005091987A2 (en) | 2004-03-19 | 2005-10-06 | Axonyx, Inc. | Method of treating down syndrome |
| EP1740172A4 (en) * | 2004-03-19 | 2007-10-10 | Axonyx Inc | ACETYLCHOLINESTERASE INHIBITORS AND N-METHYL-D-ASPARTATE ANTAGONISTS FOR THE TREATMENT OF COGNITIVE DISORDER |
| US9095573B2 (en) * | 2005-08-01 | 2015-08-04 | University Of Central Florida Research Foundation, Inc. | Method of biasing implanted human neural stem cells away from differentiation into glial cells by (+)phenserine to modulate the concentration of soluble βAPP in tissue or CSF |
| RU2327480C1 (ru) | 2007-05-23 | 2008-06-27 | Виктор Иванович Рощин | Активный ингредиент лекарственного средства, лекарственное средство, фармацевтическая композиция и способ лечения больных с дементным синдромом |
| US9006283B2 (en) | 2007-07-12 | 2015-04-14 | Acumen Pharmaceuticals, Inc. | Methods of modifying amyloid β oligomers using non-peptidic compounds |
| US8962677B2 (en) | 2007-07-12 | 2015-02-24 | Acumen Pharmaceuticals, Inc. | Methods of restoring cognitive ability using non-peptidic compounds |
| US20120225922A1 (en) | 2011-03-04 | 2012-09-06 | Qr Pharma | Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration |
| DK3334425T3 (da) | 2015-08-14 | 2021-02-22 | Qr Pharma | Methods of treatment or prevention of acute brain or nerve injuries |
| US10864192B2 (en) | 2016-01-15 | 2020-12-15 | Aristea Translational Medicine Corporation | Compositions and methods for inhibiting brain trauma-induced neurodegeneration and related conditions |
| US10111860B1 (en) | 2016-01-15 | 2018-10-30 | Aristea Translational Medicine Corporation | Compositions and methods for treating concussion |
| WO2017214197A1 (en) | 2016-06-06 | 2017-12-14 | University Of Central Florida Research Foundation, Inc. | Combination therapy to improve brain function or promote neurogenesis for treating neurodegenerative conditions |
| EP3654957A4 (en) * | 2017-05-24 | 2021-06-23 | Annovis Bio, Inc. | PREVENTION OR TREATMENT OF DISEASE CONDITIONS DUE TO METAL DIS-HOMEOSTASIS BY ADMINISTERING POSIPHES TO HEALTHY OR SICK PEOPLE |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1349858B1 (en) * | 2000-11-02 | 2008-08-27 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof |
-
2003
- 2003-03-12 US US10/386,915 patent/US20040024043A1/en not_active Abandoned
- 2003-03-18 RU RU2004131214/14A patent/RU2280449C2/ru not_active IP Right Cessation
- 2003-03-18 IL IL16399303A patent/IL163993A0/xx unknown
- 2003-03-18 JP JP2003579808A patent/JP2005526806A/ja active Pending
- 2003-03-18 MX MXPA04009136A patent/MXPA04009136A/es unknown
- 2003-03-18 CN CNA038066815A patent/CN1642541A/zh active Pending
- 2003-03-18 NZ NZ534726A patent/NZ534726A/en unknown
- 2003-03-18 WO PCT/US2003/008407 patent/WO2003082270A1/en active IP Right Grant
- 2003-03-18 BR BR0306855-2A patent/BR0306855A/pt not_active IP Right Cessation
- 2003-03-18 CA CA002476923A patent/CA2476923A1/en not_active Abandoned
- 2003-03-18 AU AU2003230683A patent/AU2003230683B2/en not_active Ceased
- 2003-03-18 KR KR1020047014635A patent/KR100609381B1/ko not_active IP Right Cessation
- 2003-03-18 PL PL03372315A patent/PL372315A1/xx unknown
- 2003-03-18 EP EP03723773A patent/EP1490057A4/en not_active Withdrawn
-
2004
- 2004-10-21 HR HR20040992A patent/HRP20040992A2/hr not_active Application Discontinuation
- 2004-10-21 NO NO20044530A patent/NO20044530L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003230683A1 (en) | 2003-10-13 |
| HRP20040992A2 (en) | 2005-02-28 |
| IL163993A0 (en) | 2005-12-18 |
| US20040024043A1 (en) | 2004-02-05 |
| KR20040101319A (ko) | 2004-12-02 |
| NZ534726A (en) | 2006-06-30 |
| WO2003082270A1 (en) | 2003-10-09 |
| EP1490057A4 (en) | 2007-07-11 |
| JP2005526806A (ja) | 2005-09-08 |
| KR100609381B1 (ko) | 2006-08-08 |
| CA2476923A1 (en) | 2003-10-09 |
| AU2003230683B2 (en) | 2006-04-06 |
| CN1642541A (zh) | 2005-07-20 |
| MXPA04009136A (es) | 2004-12-07 |
| RU2004131214A (ru) | 2005-04-10 |
| PL372315A1 (en) | 2005-07-11 |
| RU2280449C2 (ru) | 2006-07-27 |
| EP1490057A1 (en) | 2004-12-29 |
| BR0306855A (pt) | 2005-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0318447D0 (en) | Therapeutic agents | |
| GB0225475D0 (en) | Therapeutic agents | |
| NO20035474D0 (no) | Prodrugs av GABA-analoger, sammensetninger og anvendelse derav | |
| EA200900802A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
| NO20053263L (no) | Hydroksyetylaminderivater for behandling av Alzheimers sykdom. | |
| NO20053855L (no) | 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer. | |
| DE60219917D1 (de) | Naphtoquinone derivate als inhibitoren von tau aggregation zur behandlung von alzheimer's und verbundenen neurodegenerativen erkrankungen | |
| EA200600078A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
| NO20034056D0 (no) | Proliferative sykdommer | |
| ATE408601T1 (de) | Fredericamycin-derivate | |
| EP1562897A4 (en) | PHENYL ACARBOXAMIDE AS A BETA SEKRETASE INHIBITOR FOR THE TREATMENT OF ALZHEIMER | |
| MY144483A (en) | 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases | |
| DE60126980D1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| BR0116370A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente. | |
| NO20052267L (no) | Forbindelser, Preparater og Metoder | |
| BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
| NO20060020L (no) | 3-fluorpiperidiner som NMDA/NR2B-antagonister | |
| ATE357438T1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
| NO20044530L (no) | Fremgangsmate for behandling av kognitive forstyrrelser | |
| DE60315479D1 (de) | Pyrimidinamid derivate und deren verwendung | |
| CY1106155T1 (el) | Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους | |
| NO20055450L (no) | Kombinasjon av et analeptisk modafinili og en antidepressiv forbindelse for behandling av depresjon | |
| CY1109666T1 (el) | Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας | |
| MY139368A (en) | Novel cyclohexyl sulphones | |
| MX2021002936A (es) | Uso de recambio plasmatico de bajo volumen para el tratamiento de la enfermedad de alzheimer en etapas temprana y moderada. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |